---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-024960"
form_type: "8-K"
ticker: "QCLS"
cik: "0001321834"
company_name: "Q/C TECHNOLOGIES, INC."
filed_at: "2024-06-24T23:59:59+00:00"
generated_at: "2026-06-01T02:24:20.194233+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# MyMD Pharmaceuticals increases authorized Series G Preferred shares from 8,950 to 12,826,273 for in-kind dividends

## Summary
- On June 17, 2024, MyMD filed a Certificate of Amendment to increase authorized Series G Convertible Preferred Stock from 8,950 to 12,826,273 shares.
- The amendment enables payment of dividends 'in kind' in the form of additional Preferred Stock shares, per Section 3 of the Certificate of Designations.
- The amendment was approved by Required Holders and became effective upon filing with the Delaware Secretary of State.
- The Company had previously entered into a Securities Purchase Agreement on May 20, 2024 for sale of Preferred Stock and warrants.

## SEC filing metadata
- accession: 0001493152-24-024960
- form_type: 8-K
- ticker: QCLS
- cik: 0001321834
- company_name: Q/C TECHNOLOGIES, INC.
- filed_at: 2024-06-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321834/000149315224024960/0001493152-24-024960-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321834/000149315224024960/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-024960
- JSON: https://secwatch.observer/filing/0001493152-24-024960.json
- Plain text: https://secwatch.observer/filing/0001493152-24-024960.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.